Seal Biosciences Seal Biosciences Seal Biosciences Seal Biosciences Seal Biosciences

Publications-first draft

Milestones

150 150 Seal Biosciences

September 2020 – Seal Biosciences receives Notice of Publication for patent application 16/878,973 entiltled “Prognostic and Diagnostic Methods for Colorectal Cancer” April 2020 – Seal Biosciences successfully executes limited fundraising round December 2019 – Roose lab at UCSF generates new RasGRP1 antibodies August 2019 – JCI Insight publication supporting value of RasGRP1 as prognostic marker…

read more